DRIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

DarioHealth Corp.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026

$4.49−0.33 (-6.85%)

Close on Oct 19, 2026

Market cap: $41.95M
P/E (TTM): 1.1
Dividend yield: –

DarioHealth Corp. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31
Revenue	22	27	20	28	21	7.58	7.56	7.39	5.17	2.80	0.82	0.05	0	–
Cost of Revenue	9.69	14	14	18	17	5.06	4.96	5.63	3.86	3.36	1.68	2.27	0	–
Gross Profit	13	13	5.98	9.66	3.96	2.51	2.60	1.77	1.31	-0.83	-0.86	-2.71	0	–
Research & Development	14	24	20	20	17	4.43	3.69	3.68	3.30	2.15	2.57	3.94	4.91	1.50
General & Administrative	15	20	18	16	24	13	5.48	5.47	4.73	3.38	2.95	3.64	6.30	2.18
Advertising Expenses	20	26	24	30	40	15	11	10	7.71	4.74	1.33	1.06	0.18	0.16
Operating Expenses	49	71	62	66	80	32	20	19	16	10	6.84	8.65	14	–
Operating Income	-37	-58	-56	-57	-76	-30	-18	-18	-14	-11	-7.70	-11	-14	-3.97
Interest Expense	3.02	–	–	1.88	–	–	–	–	–	–	–	–	–	–
Interest & Investment Income	0.94	1.12	1.87	0.51	0.04	0.06	0.02	0	–	–	–	–	–	–
Other Non-Operating Income	-4.95	13	-3.17	-5.38	-0.24	0.46	-0.03	-0.12	-1.32	0.21	0.56	-1.52	-0.37	-1.71
Asset Impairment Charges	0	0.86	0	0	0	0	0	0	0	0.27	0	0.49	0	0
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	–	0	-0.03	0	0.01	0	–	–
Pretax Income	-42	-45	-59	-62	-77	-29	-18	-18	-16	-11	-7.14	13	14	5.69
Income Tax Expense	0.11	-1.85	0.06	0.00	0.03	–	–	–	–	–	–	–	–	–
Income from Continuing Operations	42	43	–	–	–	–	–	–	–	–	–	–	–	–
Net Income incl. Noncontrolling Interests	-42	-43	-59	-62	-77	-29	–	–	–	–	–	–	–	–
Net Income	-42	-43	-59	-62	-77	-29	-18	-18	-16	-11	-7.14	-13	-14	-5.69
Preferred Dividends	–	–	–	–	–	–	–	–	–	0.27	0	2.90	0	–
Net Income to Common	–	–	–	-60	-68	-33	-21	-18	-16	-12	-7.30	-16	-14	–
EPS (Basic)(per share)	10.12	12.27	1.93	2.54	4.07	4.01	8.00	15.63	32.80	41.80	76.80	666.00	1,368.00	828.00
EPS (Diluted)(per share)	10.12	12.27	1.93	2.54	4.07	4.01	8.00	15.63	32.80	41.80	76.80	666.00	1,368.00	828.00
Shares Outstanding (Basic, Weighted)(shares)	3.98	2.45	28	24	17	5.96	2.27	1.17	0.48	0.26	0.09	0.02	0.01	0.01
Shares Outstanding (Diluted, Weighted)(shares)	3.98	2.45	28	24	17	5.96	2.27	1.17	0.48	0.26	0.09	0.02	0.01	0.01

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 58.2%
Operating margin: -151.6%
Net margin: -169.9%
Return on equity, FY2025: -59.6%

Financial strength

Current ratio: 2.31
Debt to equity: 0.56
Debt to assets: 32.2%
Cash to current liabilities: 69.3%

Valuation

P/E ratio: 1.1
Price to sales: 2.00
Price to book: 0.76
Dividend yield: –